Tag: ADHD
-
Brain Device for ADHD Shows No Benefit in Major UK Trial
UK trial finds no benefit from brain device in ADHD treatment The latest results from a high-profile UK clinical trial have cast doubt on the effectiveness of a brain-device approach for treating attention deficit hyperactivity disorder (ADHD). After a rigorous evaluation across multiple sites, researchers report no significant improvements in core ADHD symptoms for participants…
-
Brain device for ADHD shows no benefit in major UK trial
UK trial questions the promise of a brain device for ADHD The UK has seen a surge in ADHD diagnoses in recent years, with more children and teenagers referred for assessment and support than ever before. Amid the growing demand for effective treatments, researchers have been testing a novel brain-device approach aimed at alleviating ADHD…
-
Acetaminophen in Pregnancy: Latest Review Finds No Link to Autism, ADHD, or Intellectual Disability
Overview: What the Review Concludes A comprehensive review published recently examines whether taking acetaminophen (paracetamol) during pregnancy affects a child’s risk of neurodevelopmental conditions. The researchers conclude that when used as directed, acetaminophen does not increase the likelihood of autism spectrum disorder (ASD), attention-deficit/hyperactivity disorder (ADHD), or intellectual disability in offspring. This finding helps clarify…
-
Acetaminophen in Pregnancy: Review Finds No Autism or ADHD Risk
New Findings on Acetaminophen Use During Pregnancy A major review published recently provides reassurance to expectant families: when taken as directed, acetaminophen (also known as paracetamol) during pregnancy does not increase the likelihood that a child will develop autism spectrum disorder (ASD), attention-deficit/hyperactivity disorder (ADHD), or intellectual disability. This has long been a concern for…
-
Youth ADHD Treatment Barriers and Outcomes: Insights from APSARD 2026
Overview: What APSARD 2026 Revealed About Adolescent ADHD The opening session of the APSARD 2026 conference brought renewed attention to the persistent barriers that adolescents face in accessing effective ADHD treatment. Researchers and clinicians shared data showing that youths diagnosed in childhood often navigate a complex path to sustained care, with outcomes that vary widely…
-
Youth ADHD Treatment Barriers and Outcomes: Insights from APSARD 2026 Conference
Overview: Why APSARD 2026 Matters for Youth ADHD The opening session of the APSARD 2026 conference spotlighted a critical issue in child and adolescent mental health: disparities in access to ADHD treatment and how early diagnosis and intervention shape long‑term outcomes. Researchers and clinicians gathered to discuss barriers that families face, from misperceptions about ADHD…
-
ADHD Drug Prescriptions Surge in Korea Youth: Risks and Safeguards
Overview: A rising trend in ADHD treatment among Korean youth In recent years, South Korea has seen a notable increase in prescriptions for methylphenidate, a stimulant medication commonly used to treat attention deficit hyperactivity disorder (ADHD). While access to effective ADHD treatment can help many young people manage symptoms and improve school performance, the surge…
-
ADHD Drug Surge in Korea Sparks Urgent Safety Concerns for Youth
Overview: A Sharp Rise in ADHD Treatments Among Youth In South Korea, a notable increase in prescriptions for methylphenidate, a stimulant commonly used to treat attention deficit hyperactivity disorder (ADHD), has drawn attention from health professionals, parents, and policymakers. Data from the first nine months of recent years indicate that medication use among children and…
-
Rising ADHD Drug Prescriptions in Korea Spark Concerns Over Misuse
Overview: A Sharp Rise in ADHD Medication Prescriptions In South Korea, prescriptions for methylphenidate, a stimulant medication commonly used to treat attention deficit hyperactivity disorder (ADHD), have surged among children and adolescents. Health authorities and researchers report a notable uptick in the first nine months of a recent year, drawing attention to potential misuse risks,…
-
How Brain Imaging Sheds Light on Why Stimulants Boost ADHD Performance
Understanding the Promise of Stimulants in ADHD Stimulant medications like methylphenidate (Ritalin) and amphetamine-based drugs (Adderall) have long been a cornerstone in treating attention deficit hyperactivity disorder (ADHD). While their effectiveness is well documented in clinical practice, recent brain imaging studies are clarifying exactly how these medications alter brain activity to improve attention, impulse control,…